The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial - Concepedia

Concepedia

Publication | Open Access

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

DOI Full Paper Access

33

Citations

18

References

2018

Year

Kenneth E. Schmader, Myron J. Levin, Katrijn Grupping, Sean Matthews, David Butuk, Michael Chen, Mohamed El Idrissi, Laurence Fissette, Charles Fogarty, Paul Hartley,

The Journals of Gerontology Series A

Abstract

Overall, the physical functioning and quality of life of older adults were not affected by a first RZV dose. The observed reactogenicity was consistent with previous studies.

References

	Year	Citations

Page 1